🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 4 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/07/2014 | 93,78 | 94,67 | 92,15 | 92,33 | -1,55% | 2,69% | 412.600 |
| 23/07/2014 | 93,83 | 95,73 | 92,51 | 93,78 | +0,57% | 3,43% | 407.700 |
| 22/07/2014 | 92,56 | 93,98 | 91,93 | 93,25 | +1,39% | 2,21% | 437.800 |
| 21/07/2014 | 90,98 | 92,19 | 89,60 | 91,97 | +0,49% | 2,85% | 547.800 |
| 18/07/2014 | 89,81 | 91,63 | 89,81 | 91,52 | +1,98% | 2,03% | 883.600 |
| 17/07/2014 | 90,45 | 91,35 | 89,36 | 89,74 | -1,04% | 2,20% | 519.700 |
| 16/07/2014 | 92,14 | 92,33 | 90,19 | 90,68 | -0,82% | 2,32% | 537.700 |
| 15/07/2014 | 92,45 | 94,40 | 91,19 | 91,43 | -1,83% | 3,47% | 995.800 |
| 14/07/2014 | 94,00 | 94,00 | 92,26 | 93,13 | -0,14% | 1,85% | 551.000 |
| 11/07/2014 | 93,09 | 93,82 | 91,86 | 93,26 | +0,33% | 2,11% | 324.300 |
| 10/07/2014 | 92,46 | 93,80 | 91,14 | 92,95 | -0,23% | 2,88% | 486.900 |
| 09/07/2014 | 92,94 | 93,57 | 91,00 | 93,16 | +0,19% | 2,77% | 854.900 |
| 08/07/2014 | 90,36 | 93,66 | 89,20 | 92,98 | +3,13% | 4,94% | 1.005.300 |
| 07/07/2014 | 90,55 | 91,79 | 89,76 | 90,16 | -0,46% | 2,24% | 1.082.700 |
| 03/07/2014 | 91,62 | 92,29 | 90,53 | 90,58 | -0,90% | 1,92% | 583.800 |
| 02/07/2014 | 91,65 | 93,04 | 90,86 | 91,40 | -0,09% | 2,38% | 671.100 |
| 01/07/2014 | 89,11 | 92,24 | 89,11 | 91,48 | +3,38% | 3,51% | 623.900 |
| 30/06/2014 | 89,62 | 90,84 | 88,42 | 88,49 | -1,07% | 2,70% | 587.200 |
| 27/06/2014 | 91,30 | 91,30 | 88,05 | 89,45 | +1,61% | 3,56% | 804.000 |
| 26/06/2014 | 88,19 | 88,76 | 86,13 | 88,03 | +0,03% | 2,98% | 290.500 |
| 25/06/2014 | 87,45 | 88,41 | 86,94 | 88,00 | +0,30% | 1,68% | 485.200 |
| 24/06/2014 | 87,41 | 90,30 | 87,41 | 87,74 | +0,02% | 3,31% | 746.900 |
| 23/06/2014 | 87,80 | 89,99 | 86,68 | 87,72 | +0,30% | 3,77% | 478.500 |
| 20/06/2014 | 87,43 | 89,27 | 86,43 | 87,46 | +0,51% | 3,25% | 1.187.100 |
| 19/06/2014 | 84,97 | 87,04 | 84,63 | 87,02 | +1,02% | 2,84% | 764.300 |
| 18/06/2014 | 86,89 | 87,44 | 84,94 | 86,14 | -0,19% | 2,88% | 1.393.800 |
| 17/06/2014 | 90,11 | 90,55 | 86,07 | 86,30 | -4,59% | 4,97% | 1.862.000 |
| 16/06/2014 | 89,66 | 99,37 | 89,24 | 90,45 | +0,91% | 11,30% | 2.030.800 |
| 13/06/2014 | 97,25 | 98,04 | 89,46 | 89,63 | -7,97% | 8,82% | 1.697.500 |
| 12/06/2014 | 98,24 | 99,36 | 96,90 | 97,39 | -1,00% | 2,50% | 394.700 |